February 8, 2013

In the second article of her “Navigating Emerging Markets” series seen in BioPharm International, NAI Senior Consultant Jill E. Sackman, D.V.M., Ph.D., tackles the region-specific challenges of Eastern Europe, and the implications for successful market entry and partnerships. Jill highlights critical information about regulatory harmonization with the EU, differential progress and political dynamics by country that pharmaceutical companies will need to engage the market.

Click here to read Navigating Emerging Markets — Eastern Europe, published in BioPharm International February 2013.